It was the first report to indicate that sesamol could alleviate obesity and its related metabolic disorders via regulating glucose and lipid metabolism of skeletal muscle in the middle-aged mice, which might be associated with the stimulation of the SIRT1/AMPK pathway (Fig. 8). Here, PRKAA2 is linked to obesity due to melanocortin 4 receptor deficiency.